Skip to main content
. 2021 Aug 10;11:16233. doi: 10.1038/s41598-021-95667-3

Table 1.

Comparison of demographics and clinical characteristics of patients with OSA and controls.

OSA (n = 27) Controls (n = 29) P
Age (years) 60/53–68/ 41/28–54/  < 0.01
Gender (male %) 33 28 0.64
BMI (kg/m2) 26.6/23.3–29.6/ 24.4/21.0–27.7/ 0.05
Smoker (ever %) 26 3 0.01
Hypertension (%) 67 28  < 0.01
Cardiovascular or cerebrovascular disease (%) 26 3 0.01
Depression (%) 7 3 0.51
Diabetes (%) 22 10 0.22
Dyslipidaemia (%) 48 38 0.44
Asthma (%) 11 7 0.58
COPD (%) 7 3 0.51
Osteoporosis (%) 19 0 0.01
Aspirin use 7 22 0.03
Opioid use 4 0 0.30
ESS 6/4.5–10.5/ 6 0.76
TST (min) 394/378–430/ 416/362–424/ 0.67
SPT (min) 435/406–462/ 425/407–437/ 0.41
Sleep % 95/89–98/ 96/92–99/ 0.32
AHI (1/h) 9.4/6.5–14.2/ 2.3/1.0–2.8/  < 0.01
ODI (1/h) 8.4/4.9–11.2/ 0.9/0.2–1.7/  < 0.01
TST90% (%) 1.3/0.2–2.9/ 0.0/0.0–0.0/  < 0.01

AHI apnoea-hypopnoea index, BMI body mass index, COPD chronic obstructive pulmonary disease, ESS Epworth Sleepiness Scale, ODI oxygen desaturation index, OSA obstructive sleep apnoea, Sleep%—sleep efficiency, SPT sleep period time, TST total sleep time, TST90% percentage of total sleep time spent with oxygen saturation below 90%. Data are presented as median /interquartile range/